The company, recognised as the Fastest Growing Pharmaceutical Company at the ET Business Excellence & Leadership Awards 2026, is expanding beyond its core nasal drug delivery business with a new sterile injectables facility.
The pharmaceutical industry is seeing continued demand for specialised drug delivery systems and expanded manufacturing capabilities. For companies looking to grow in this environment, the challenge lies in building on established expertise while developing capabilities in new product segments.
